Form 4: 10x Genomics CEO Reports Stock Transaction
Insider Transaction (Form 4)
Serge Saxonov, Chief Executive Officer and a Director of 10x Genomics, Inc., reported a transaction in 4,000 shares of common stock on August 20, 2026.
Summary
- Bona fide gift: disposed of 4,000 Class A Common Stock on August 20, 2026; holds 1,104,380 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Serge Saxonov — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-20 | Bona fide gift | Class A Common Stock | 4,000 | — | — | 1,104,380 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-20 | Bona fide gift (4,000 shares) |
Keywords
insider transaction, Form 4, TXG, 10x Genomics, Inc., neutral, Serge Saxonov
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.